Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The management of the poor responder patients is very difficult. Currently, there is no any
standard treatment for poor responder patients. The study is designed to test a modified
GnRHa protocol for poor ovarian response, low dose GnRHa early luteal phase down regulation,
compare with GnRHa ultra-short protocol. This is a randomized controlled trial.